Simulations Plus EPS - Earnings per Share 2010-2024 | SLP
Simulations Plus eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Simulations Plus Annual EPS |
| 2023 |
$0.49 |
| 2022 |
$0.60 |
| 2021 |
$0.47 |
| 2020 |
$0.50 |
| 2019 |
$0.48 |
| 2018 |
$0.50 |
| 2017 |
$0.33 |
| 2016 |
$0.29 |
| 2015 |
$0.23 |
| 2014 |
$0.18 |
| 2013 |
$0.18 |
| 2012 |
$0.19 |
| 2011 |
$0.17 |
| 2010 |
$0.13 |
| 2009 |
$0.08 |
| Simulations Plus Quarterly EPS |
| 2024-02-29 |
$0.20 |
| 2023-11-30 |
$0.10 |
| 2023-08-31 |
$0.03 |
| 2023-05-31 |
$0.20 |
| 2023-02-28 |
$0.20 |
| 2022-11-30 |
$0.06 |
| 2022-08-31 |
$0.04 |
| 2022-05-31 |
$0.20 |
| 2022-02-28 |
$0.21 |
| 2021-11-30 |
$0.15 |
| 2021-08-31 |
$0.02 |
| 2021-05-31 |
$0.18 |
| 2021-02-28 |
$0.15 |
| 2020-11-30 |
$0.12 |
| 2020-08-31 |
$0.11 |
| 2020-05-31 |
$0.16 |
| 2020-02-29 |
$0.12 |
| 2019-11-30 |
$0.11 |
| 2019-08-31 |
$0.11 |
| 2019-05-31 |
$0.16 |
| 2019-02-28 |
$0.12 |
| 2018-11-30 |
$0.09 |
| 2018-08-31 |
$0.08 |
| 2018-05-31 |
$0.13 |
| 2018-02-28 |
$0.19 |
| 2017-11-30 |
$0.10 |
| 2017-08-31 |
$0.06 |
| 2017-05-31 |
$0.12 |
| 2017-02-28 |
$0.07 |
| 2016-11-30 |
$0.08 |
| 2016-08-31 |
$0.05 |
| 2016-05-31 |
$0.11 |
| 2016-02-29 |
$0.07 |
| 2015-11-30 |
$0.06 |
| 2015-08-31 |
$0.03 |
| 2015-05-31 |
$0.11 |
| 2015-02-28 |
$0.06 |
| 2014-11-30 |
$0.03 |
| 2014-08-31 |
$0.01 |
| 2014-05-31 |
$0.08 |
| 2014-02-28 |
$0.05 |
| 2013-11-30 |
$0.04 |
| 2013-08-31 |
$0.02 |
| 2013-05-31 |
$0.06 |
| 2013-02-28 |
$0.06 |
| 2012-11-30 |
$0.04 |
| 2012-08-31 |
$0.03 |
| 2012-05-31 |
$0.05 |
| 2012-02-29 |
$0.05 |
| 2011-11-30 |
$0.06 |
| 2011-08-31 |
$0.01 |
| 2011-05-31 |
$0.07 |
| 2011-02-28 |
$0.05 |
| 2010-11-30 |
$0.03 |
| 2010-08-31 |
$0.02 |
| 2010-05-31 |
$0.04 |
| 2010-02-28 |
$0.04 |
| 2009-11-30 |
$0.03 |
| 2009-08-31 |
$0.01 |
| 2009-05-31 |
$0.03 |
| 2009-02-28 |
$0.02 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$1.018B |
$0.060B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
